SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richaaard who wrote (564)1/21/2000 1:16:00 PM
From: Susan G  Read Replies (2) of 1154
 
GENE filed for a secondary Offering...
Celera Genomics Scheduled at 4th Beltway Biotech Forum Saturday

======================================================================
WASHINGTON DC--(BW Healthwire)--Jan. 21, 2000--Celera Genomics
(NYSE:CRA) plans to join the lineup tomorrow at the 4th Beltway
Biotech Forum in Bethesda, MD.
The Celera Genomics Group, headquartered in Rockville, Md.,
intends to become the definitive source of genomic and related medical
information. The company announced January 10th that efforts to map
the entire human genome were 90%, likely encompassed 97% of human
genes and should be completed and should be finished this year.
Parent company PE Corp. also announced today a two-for-one stock
split The split will be effected in the form of a 100 percent stock
dividend payable to stockholders of record as of the close of business
on February 4, 2000. The distribution date of the stock dividend is
February 18, 2000.
Gene Logic (NASDAQ:GLGC), also of Rockville, MD was scheduled to
present, but announced late last week that it has filed with the SEC
to offer 3.5 million shares to the public and would be unable to
present. Under SEC rules, companies must assume a "quiet period" for a
period of time before and after a public offering. This affects all
scheduled appearances before investors. Celera has been scheduled
instead.
The forum will run from 8:30 a.m.-1:30 p.m. Attendance costs $25
prepaid, $40 at the door, which includes a brunch. To register, go to
www.informedinvestors.com or call 800-992-4683 for more information.
Kris Jenner, M.D., Ph.D., biotechnology analyst for the T. Rowe Price
family of funds, keynotes, and other presenting companies include
beltway firms Entremed, Martek, Epix Medical and Novavax.

InformedInvestors.com is the leading producer of online and
offline industry-specific investment conferences for individual
investors and offers a growing stable of resources for in-depth
sector-analysis, including "Biotalk," a life sciences-oriented radio
program airing Wednesdays on WMET 1150 in Gaithersburg, MD, and at
Yahoo! Broadcast. Click to the live stream at
www.informedinvestors.com under Radio Shows.

CONTACT: Informed Investors
Steve Chanecka, Tim Quast, 916-780-6100 or 800-992-4683

KEYWORD: DISTRICT OF COLUMBIA MARYLAND
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com

Copyright 2000, Business Wire
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext